Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury.
about
The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseOverview of Traumatic Brain Injury: An Immunological ContextCharacterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP.Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.A Role of Serum-Based Neuronal and Glial Markers as Potential Predictors for Distinguishing Severity and Related Outcomes in Traumatic Brain Injury.Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study.Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation.Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.Addressing the needs of traumatic brain injury with clinical proteomics.Enteric GFAP expression and phosphorylation in Parkinson's disease.New astroglial injury-defined biomarkers for neurotrauma assessment.ZCCHC17 is a master regulator of synaptic gene expression in Alzheimer's Disease.UCH-L1 and GFAP Serum Levels in Neonates with Hypoxic-Ischemic Encephalopathy: A Single Center Pilot Study.Implantation of 3D Constructs Embedded with Oral Mucosa-Derived Cells Induces Functional Recovery in Rats with Complete Spinal Cord Transection.
P2860
Q26853347-F4A98326-1C22-4FF9-AD5B-E4DA898C8BBEQ30238775-AEF19583-F937-4C06-B1E4-97D14810429DQ33888244-6A0B459D-D361-4FED-A10B-C4F270C8661DQ35131093-3AB70641-93B6-4B05-94B0-8BE47A13B146Q35376450-BBD72469-7219-4FD7-BEED-F1B07945708FQ36044131-F7105607-4273-4A0B-B77B-4068911B423CQ36098256-7C635D58-BF23-4F7C-A5A8-DD4485C58215Q37115239-A18CC98C-967D-40F3-90FA-B34A86F18997Q37323740-CF252278-F91B-4C58-9518-088C8E4AA1A2Q37430560-09B00E27-8D0A-4EC8-918F-FF03A65BADADQ37685775-729A3EBF-55E3-4061-8A54-F10DABDAAF18Q39002538-CDB26483-C4EB-4B9F-95F2-20125DFF7F3BQ42005136-7A7CF162-0FA9-4150-B468-39B86D406821Q42696205-52C49CFE-D7C0-4050-A425-67A89469C885Q43072831-3511D8D3-84B6-4B8B-BF3F-3FAE1545DB34Q47095376-189FD771-FCFE-48C8-9CA8-9B5939C0BFF6
P2860
Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury.
@en
type
label
Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury.
@en
prefLabel
Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury.
@en
P2093
P2860
P356
P1433
P1476
Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury.
@en
P2093
Aarti Chawla
Boxuan Yang
Dancia Scharf
J Susie Zoltewicz
Kimberly J Newsom
Lijuan Fang
P2860
P356
10.4137/BMI.S9873
P577
2012-06-25T00:00:00Z